EUVIMEDEUVIMED entdecken
Crossref

Monoclonal Anti-CD47 Therapy and its Haematological Effects, including Anaemia and Thrombocytopenia

Journal of Emergency Medicine, Trauma and Surgical Care · 30.08.2024 · 10 (1) · 1-8

DOI: 10.24966/ets-8798/100070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Emergency Medicine, Trauma and Surgical Care, online erschienen am 30.08.2024.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoclonal anti-CD47 therapy is a new form of immunotherapy, which has been used in a clinical setting in recent years for the treatment of haematological and solid malignancies. Anti-CD47 functions by blocking the CD47-SIRPα interaction and promotes the phagocytosis of cancer cells, which attempt to invade the immune systems mechanisms via this interface.

Zitieren

APA

(2024). Monoclonal Anti-CD47 Therapy and its Haematological Effects, including Anaemia and Thrombocytopenia. Journal of Emergency Medicine, Trauma and Surgical Care, 10(1), 1-8. https://doi.org/10.24966/ets-8798/100070

Vancouver

Monoclonal Anti-CD47 Therapy and its Haematological Effects, including Anaemia and Thrombocytopenia. Journal of Emergency Medicine, Trauma and Surgical Care. 2024;10(1):1-8. doi:10.24966/ets-8798/100070

BibTeX
@article{euvimed2024,
  title = {Monoclonal Anti-CD47 Therapy and its Haematological Effects, including Anaemia and Thrombocytopenia},
  journal = {Journal of Emergency Medicine, Trauma and Surgical Care},
  year = {2024},
  volume = {10},
  number = {1},
  pages = {1--8},
  doi = {10.24966/ets-8798/100070}
}
Kostenlos starten →